Search results
Trehalose is enabling life-changing protein therapeutics and exosomes
Nature· 2 hours agoTrehalose is vital to the biopharma industry. Manufacturers of monoclonal antibodies and other protein therapeutics use this saccharide to stabilize molecules that would otherwise be degraded ...
Zenas, with new funding, aims dual-targeting antibody at lupus and MS
BioPharma Dive via Yahoo Finance· 16 hours agoThe $200 million round is the latest evidence that surging interest in autoimmune disease cell...
New Cancer 'Missile' Drugs May Be More Effective Than Traditional Chemotherapy
Verywell Health via Yahoo News· 5 days agoHealth Fact checked by Nick Blackmer Key Takeaways The FDA recently approved a new type of treatment...
Zenas adds $200M series C to reach a bucket of key readouts for its lead monoclonal antibody
FierceBiotech· 16 hours agoZenas BioPharma has bagged a $200 million series C, extending its cash runway another 18 months...
AbCellera Biologics Inc (ABCL) Q1 2024 Earnings: Misses Revenue
Guru Focus· 5 hours agoOn May 7, 2024, AbCellera Biologics Inc (ABCL, Financial) released its financial results for the first quarter of 2024 through an 8-K filing. The company, known for its advanced antibody ...
Opko Health (OPK) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 hour agoModeX continues to advance its development work, and two programs are on track to enter the clinic this year, our Epstein-Barr vaccine, licensed to...
Rani Therapeutics Q1 2024 Earnings: Financial Performance and Strategic Updates
GuruFocus.com via Yahoo Finance· 2 hours agoCEO Talat Imran highlighted the potential of RT-111 to offer a favorable product profile in the...
...-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on...
FOX 59 Indianapolis· 5 days agoTarcocimab clinical and non-clinical data highlight strong 6-month efficacy profile in diabetic...
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Short Interest Up 6.9% in April
ETF DAILY NEWS· 7 days agoImmunoPrecise Antibodies Ltd. (NASDAQ:IPA – Get Free Report) was the target of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling ...
Researchers make strides in understanding little-known autoimmune myelin-impairing disorder
Medical Xpress· 10 hours agoIn a new study published in the Journal of Neurology, Neurosurgery & Psychiatry, the researchers detail the discovery of a way to predict which adult patients will experience a relapsing course ...